Astrocyte-derived factors regulate CNS myelination

Glia. 2024 Nov;72(11):2038-2060. doi: 10.1002/glia.24596. Epub 2024 Aug 2.

Abstract

The role that astrocytes play in central nervous system (CNS) myelination is poorly understood. We investigated the contribution of astrocyte-derived factors to myelination and revealed a substantial overlap in the secretomes of human and rat astrocytes. Using in vitro myelinating co-cultures of primary retinal ganglion cells and cortical oligodendrocyte precursor cells, we discovered that factors secreted by resting astrocytes, but not reactive astrocytes, facilitated myelination. Soluble brevican emerged as a new enhancer of developmental myelination in vivo, CNS and its absence was linked to remyelination deficits following an immune-mediated damage in an EAE mouse model. The observed reduction of brevican expression in reactive astrocytes and human MS lesions suggested a potential link to the compromised remyelination characteristic of neurodegenerative diseases. Our findings suggested brevican's role in myelination may be mediated through interactions with binding partners such as contactin-1 and tenascin-R. Proteomic analysis of resting versus reactive astrocytes highlighted a shift in protein expression profiles, pinpointing candidates that either facilitate or impede CNS repair, suggesting that depending on their reactivity state, astrocytes play a dual role during myelination.

Keywords: ACM; MS; astrocytes; brevican; myelination; reactive astrocytes.

MeSH terms

  • Animals
  • Astrocytes* / metabolism
  • Brevican / metabolism
  • Cells, Cultured
  • Central Nervous System* / metabolism
  • Coculture Techniques
  • Encephalomyelitis, Autoimmune, Experimental / metabolism
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Female
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Myelin Sheath* / metabolism
  • Oligodendroglia / metabolism
  • Rats
  • Remyelination / physiology

Substances

  • Brevican